Effect of Precariousness in RUral Areas During preGNANCY

NCT02275442 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 190

Last updated 2014-10-27

No results posted yet for this study

Summary

The link between precarious situations and health conditions are more described in previous study. Precarious situations are more frequent and complex especially in rural areas. There are recognized like a risk factor of complications during pregnancy and delivery. It's necessary to describe antenatal cares for rural women in precarious situations to prevent those situations, to understand their difficulties in order to reduce inequalities and health spending.

The aim of the PRUGNANCY study is to understand the difficulties of rural parturient women and the strategies developed to overcome them. Recognized earlier precarious situations and valorized General Practitioners and restore them to the follow-up or parturient women.

Conditions

  • Pregnancy
  • Rural Parturient Women
  • Precarious Situation
  • EPICES Scale
  • General Practice

Interventions

OTHER

EPICES scale

Sponsors & Collaborators

  • Hospital Center of Issoire : Maternity unit

    collaborator UNKNOWN
  • PEPRADE label unit EA 4681 : Department of general practice - Clermont-Ferrand AND Unit of Epidemiology, economic health and prevention - C.H.U Clermont-Ferrand

    collaborator UNKNOWN
  • Perinatal cares Auvergne network - C.H.U Estaing, Clermont-Ferrand

    collaborator UNKNOWN
  • University Hospital, Clermont-Ferrand

    lead OTHER

Principal Investigators

  • Philippe VORILHON · University Hospital, Clermont-Ferrand

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02275442 on ClinicalTrials.gov